Evidence map›Paper›PMID 41737628›Full record

ArticleFrontiers in nuclear medicine2026

Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study.

Hendrea S A Tingen, Gilles N Stormezand, Paul van Snick, Yingqi Hu, Paul Van Der Zwaag, Marish Oerlemans, Peter van der Meer, Bouke P C Hazenberg, Gert Luurtsema, Hans L A Nienhuis and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hendrea S A TingenDepartment of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Gilles N StormezandDepartment of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Paul van SnickDepartment of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Yingqi HuDepartment of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Paul Van Der ZwaagDepartment of Clinical Genetics, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Marish OerlemansDepartment of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands.
Peter van der MeerDepartment of Cardiology, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Bouke P C HazenbergDepartment of Rheumatology & Clinical Immunology, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Gert LuurtsemaDepartment of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Hans L A NienhuisDepartment of Internal Medicine, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.
Riemer H J A SlartDepartment of Nuclear Medicine and Molecular Imaging, Groningen Amyloidosis Centre of Expertise, Groningen University, University Medical Centre Groningen, Groningen, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the effectiveness of positron emission tomography (PET) with [ Methods: This prospective case series included four hereditary ATTR amyloidosis patients with Results: Cardiac [ Conclusion: [

Indexed as

[11C]PiBATTR-CMATTRvbone scintigraphydiagnosisPETtype B fibrils

Identifiers

PMID41737628
PMCPMC12926488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.